Literature DB >> 3081393

Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat.

W G Robison, P F Kador, Y Akagi, J H Kinoshita, R Gonzalez, D Dvornik.   

Abstract

A diabetic-like thickening of retinal capillary basement membranes induced in rats fed for 207 consecutive days a diet containing 50% galactose was prevented by the addition to the diet of tolrestat, a potent, structurally novel inhibitor of aldose reductase. Analysis of electron micrographs (X 25,000) of capillaries from the outer plexiform layer of the retina by computer planimetry showed that the basement membranes were approximately twofold thicker in rats fed galactose than in those fed either a standard diet or a diet containing galactose and tolrestat in doses of 43 or 57 mg/kg/day. The thickening of basement membranes in galactose-fed rats was accompanied by other ultrastructural alterations mimicking changes typical of diabetic microangiopathy, such as multilamination and the formation of vacuoles and dense inclusions. Therefore, the galactosemic rat represents a useful model for studying basement membrane-related complications of diabetes and their possible prevention by aldose reductase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081393     DOI: 10.2337/diab.35.3.295

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  20 in total

1.  Pharmacokinetics of zopolrestat, a carboxylic acid aldose reductase inhibitor, in normal and diabetic rats.

Authors:  P B Inskeep; A E Reed; R A Ronfeld
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

2.  In vitro expression of rat lens aldose reductase in Escherichia coli.

Authors:  S E Old; S Sato; P F Kador; D A Carper
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 3.  Sorbitol, osmoregulation, and the complications of diabetes.

Authors:  M B Burg; P F Kador
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

4.  Prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug.

Authors:  T A Gardiner; H R Anderson; T Degenhardt; S R Thorpe; J W Baynes; D B Archer; A W Stitt
Journal:  Diabetologia       Date:  2003-07-12       Impact factor: 10.122

5.  Intervention with the aldose reductase inhibitor, tolrestat, in renal and retinal lesions of streptozotocin-diabetic rats.

Authors:  M L McCaleb; M L McKean; T C Hohman; N Laver; W G Robison
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

6.  Plasma 1,5-anhydroglucitol in experimental galactosemia in the rat.

Authors:  E Pitkänen; O M Pitkänen
Journal:  Experientia       Date:  1990-01-15

7.  Polyol formation in cell lines of rat retinal capillary pericytes and endothelial cells (TR-rPCT and TR-iBRB).

Authors:  Peter F Kador; James Randazzo; Karen Blessing; Jun Makita; Peng Zhang; Kuang Yu; Ken-Ichi Hosoya; T Terasaki
Journal:  J Ocul Pharmacol Ther       Date:  2009-08       Impact factor: 2.671

8.  Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway.

Authors:  N E Cameron; M A Cotter
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

9.  Pancreatic islet allograft prevents basement membrane thickening in the diabetic rat retina.

Authors:  A A Sima; S Chakrabarti; W J Tze; J Tai
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

10.  Cerebral cortical capillary basement membrane thickening in galactosaemic rats.

Authors:  R N Frank; S Dutta; S E Frank
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.